Simplex Trading’s AC Immune ACIU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$73.3K Sell
30,800
-16,900
-35% -$46.6K ﹤0.01% 5909
2026
Q1
$131K Buy
47,700
+17,200
+56% +$53.4K ﹤0.01% 4772
2025
Q4
$95.8K Buy
30,500
+23,900
+362% +$75.4K ﹤0.01% 5043
2025
Q3
$19K Buy
+6,600
New +$14.9K ﹤0.01% 7350
2025
Q2
Sell
-700
Closed -$1K 8488
2025
Q1
$1K Sell
700
-1,200
-63% -$3.02K ﹤0.01% 8128
2024
Q4
$5K Sell
1,900
-14,400
-88% -$45K ﹤0.01% 7561
2024
Q3
$61K Sell
16,300
-63,200
-79% -$221K ﹤0.01% 5708
2024
Q2
$317K Buy
79,500
+73,500
+1,225% +$243K ﹤0.01% 4158
2024
Q1
$17K Buy
6,000
+1,500
+33% +$5.38K ﹤0.01% 7200
2023
Q4
$22K Buy
+4,500
New +$14.5K ﹤0.01% 6833
2023
Q3
Sell
-7,200
Closed -$21K 8518
2023
Q2
$21K Buy
7,200
+6,000
+500% +$13.1K ﹤0.01% 6701
2023
Q1
$2K Buy
+1,200
New +$2.78K ﹤0.01% 8405
2022
Q2
Sell
-3,800
Closed -$15K 9816
2022
Q1
$15K Sell
3,800
-10,500
-73% -$45.5K ﹤0.01% 8503
2021
Q4
$70K Buy
14,300
+12,400
+653% +$72.1K ﹤0.01% 6773
2021
Q3
$15K Hold
1,900
﹤0.01% 8646
2021
Q2
$15K Buy
1,900
+1,880
+9,400% +$13K ﹤0.01% 8806
2021
Q1
$15K Buy
+20
New +$143 ﹤0.01% 7648

Other funds holding ACIU

Simplex Trading's ACIU Position: Q2 2026 in Review

Simplex Trading sold out of AC Immune (ACIU) in Q2 2026, closing a stake of 6,620 shares — an estimated $18.2K sold.

Simplex Trading first reported a position in ACIU in Q3 2020 and held it in 14 quarters. The position peaked at $58K in Q1 2021. 43 funds tracked by Wall St. Rank hold ACIU as of Q2 2026.

  • Simplex Trading reported no remaining AC Immune position as of Q2 2026 after selling out during the quarter.
  • Simplex Trading sold 6,620 AC Immune shares in Q2 2026, an estimated $18.2K.
  • Simplex Trading first reported a position in AC Immune in Q3 2020 and held it in 14 quarters.
  • Simplex Trading's AC Immune position peaked at $58K in Q1 2021.
  • 43 funds tracked by Wall St. Rank held AC Immune as of Q2 2026.

Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.